arsenic trioxide has been researched along with Hematologic Diseases in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cuccurullo, R; Diverio, D; Girardi, K; Gurnari, C; Lo-Coco, F; Locatelli, F; Micalizzi, C; Putti, MC; Santoro, N; Strocchio, L; Testi, AM; Zecca, M | 1 |
Ardalan, B; Subbarayan, PR | 1 |
Bazarbachi, A; de Thé, H; El Hajj, H; Farid, R; Hatoum, H; Hermine, O; Kchour, G; Kooshyar, MM; Mahmoudi, M; Maleki, M; Rafatpanah, H; Rahimi, H; Rezaee, SA; Shirdel, A; Tarhini, M; Wattel, E; Yazdi, MT | 1 |
Shan, Y | 1 |
Ma, H; Wang, C; Wang, XF; Wang, Y | 1 |
Bosly, A; Bowen, D; Burnett, A; Casadevall, N; Dennis, M; Dombret, H; Dreyfus, F; Fenaux, P; Feremans, W; Guerci, A; Legros, L; Ribrag, V; Vey, N | 1 |
Douer, D; Hainsworth, JD; List, AF; Mason, J; Rizzieri, D; Saleh, M; Schiller, GJ; Slack, J | 1 |
1 review(s) available for arsenic trioxide and Hematologic Diseases
Article | Year |
---|---|
In the war against solid tumors arsenic trioxide needs partners.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Brain Diseases; Clinical Trials as Topic; Combined Modality Therapy; Drug Approval; Drug Synergism; Hedgehog Proteins; Hematologic Diseases; Humans; Medicine, Chinese Traditional; Neoplasm Proteins; Neoplasms; Oncogene Proteins, Fusion; Oxides; Radiotherapy, Adjuvant; Signal Transduction; Thymidylate Synthase; Transcription Factors; Treatment Outcome; United States; United States Food and Drug Administration; Zinc Finger Protein GLI1 | 2014 |
3 trial(s) available for arsenic trioxide and Hematologic Diseases
Article | Year |
---|---|
Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Synergism; Female; Gastrointestinal Diseases; Hematologic Diseases; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Oxides; Proviruses; Remission Induction; Viral Load; Zidovudine | 2009 |
Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Disease-Free Survival; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Myelodysplastic Syndromes; Oxides; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Treatment Outcome | 2006 |
Phase II multicenter study of arsenic trioxide in patients with myelodysplastic syndromes.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Disease-Free Survival; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Myelodysplastic Syndromes; Oxides; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Treatment Outcome | 2006 |
3 other study(ies) available for arsenic trioxide and Hematologic Diseases
Article | Year |
---|---|
Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Child; Child, Preschool; Female; Hematologic Diseases; Humans; Leukemia, Promyelocytic, Acute; Male; Tretinoin | 2019 |
[Hematology].
Topics: Arsenic Trioxide; Arsenicals; Biomedical Research; China; Hematologic Diseases; Hematology; Humans; Oxides | 2002 |
Simultaneously multi-parameter determination of hematonosis cell apoptosis by two-photon and confocal laser scanning microscopy.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Calcium; Cell Line, Tumor; Cell Nucleus; Dose-Response Relationship, Drug; Flow Cytometry; Hematologic Diseases; Humans; Leukemia; Membrane Potentials; Microscopy, Confocal; Mitochondria; Oxides; Photons | 2004 |